PortfoliosStock ScreensStocksStockXcel

Atossa Genetics Inc

ATOS | US

5.83

USD

0.06

1.04%

ATOS | US

About Atossa Genetics Inc

Sector

Healthcare

Industry

Diagnostics & Research

Earnings date

30/06/2024

As of date

17/04/2026

Close

5.83

Open

5.81

High

5.94

Low

5.67

Atossa Therapeutics Inc. a clinical-stage biopharmaceutical company focuses on developing medicines in the areas of unmet medical need in oncology. The company's lead program is Endoxifen an active metabolite of tamoxifen which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201 for lung injury caused by cancer treatment. In addition the company develops immunotherapy/chimeric antigen receptor therapy programs. It has a research agreement with Dana-Farber Cancer Institute Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics Inc. in January 2020. Atossa Therapeutics Inc. was founded in 2008 and is headquartered in Seattle Washington.

View Less

ATOS | US

Risk
85.0
Sharpe
-0.55
Luna's Score
43/100
Recommendation
Sell

Luna says (ATOS | US)

What's Working

Value Stock (Price to Book < 3)

What's not Working

High 6-Month Volatility (>65%)

Smallcap (300M - 2B USD)

High Market Beta (> 0.8)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

10 days

66.8%

1 month

85.0%

3 months

107.2%

6 months

87.1%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

2.27

Debt to equity

-

Debt to assets

-

Ent. to EBITDA

2.01

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-30.55M

MarketCap

733.16M

MarketCap(USD)

733.16M

Div. yield

-

Op. margin

-

Erngs. growth

-

Rev. growth

-

Ret. on equity

-28.00

Short ratio

22.41

Short perc.

10.28

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Range10D

1.24

Range1M

1.50

Range3M

7.03

Volumes: Market Activity

Rel. volume

0.81

Price X volume

318.93K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
CASTLE BIOSCIENCES INCCSTLDiagnostics & Research25.05694.81M2.00%n/a5.94%
Fulgent Genetics IncFLGTDiagnostics & Research16.26492.62M0.81%n/a1.18%
Varex Imaging CorporationVREXDiagnostics & Research12.01490.74M3.53%16.6980.92%
Myriad Genetics IncMYGNDiagnostics & Research5.08461.37M1.60%n/a0.00%
Pacific Biosciences of California IncPACBDiagnostics & Research1.69460.57M3.68%n/a187.73%
Personalis IncPSNLDiagnostics & Research6.73443.75M1.05%n/a41.56%
Palatin Technologies IncPTNDiagnostics & Research22.5439.83M7.66%n/a-382.57%
National Research CorporationNRCDiagnostics & Research18.03430.40M2.33%16.76105.03%
Delcath Systems IncDCTHDiagnostics & Research10.86304.09M0.28%n/a133.18%
DarioHealth CorpDRIODiagnostics & Research7.26218.01M3.27%n/a45.01%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Janus International Group Inc.JBIBuilding Products & Equipment5.54805.08M5.73%11.62116.21%
Latham Group Inc.SWIMBuilding Products & Equipment6.34732.76M5.14%65.1877.00%
Fox Factory Holding CorpFOXFRecreational Vehicles17.37724.04M5.53%42.0564.69%
HUYA IncHUYAMedia - Diversified3.18719.86M-0.62%n/a0.00%
AMC Entertainment Holdings IncAMCMedia - Diversified1.86672.12M15.53%n/a-511.14%
The Marcus CorporationMCSMedia - Diversified19.82637.68M5.99%n/a83.32%
Ennis IncEBFBuilding Products & Equipment21.67563.50M1.69%13.282.28%
Malibu Boats IncMBUURecreational Vehicles26.54530.55M7.32%n/a1.50%
MCBC Holdings IncMCFTRecreational Vehicles23.4388.61M6.32%34.2726.82%
AMC Networks IncAMCXMedia - Diversified8.77386.74M6.56%6.32236.34%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA2.01-Cheaper
Ent. to Revenue---
PE Ratio-40.09-
Price to Book2.2777.50Cheaper
Dividend Yield---
Std. Deviation (3M)107.25-Riskier
Debt to Equity--14.36-
Debt to Assets-0.34-
Market Cap733.16M-Emerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007